At least ​20 people ‌in Japan who ​took ​Amgen's rare disease ⁠drug ​have died, ​while 22 others developed ​potentially ...

About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease ...

The latest fair value estimate for Amgen has shifted slightly, from US$350.03 to US$349.66, keeping modeled upside closely ...

Twenty people in Japan died after taking Tavneos, though it's unclear whether the drug killed those people, a media report ...

Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new ...

If you are wondering whether Amgen’s current share price reflects its true worth, starting with a clear look at what the ...

Alumis is exploring strategic alternatives for its would-be rival to Amgen’s Tepezza, choosing to punt the program rather ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

TOKYO - Japan's Kissei Pharmaceutical Co. has started urging doctors to refrain from using Tavneos, a drug used to treat rare ...

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public. | A quantum ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...